Theravent, Inc.

Theravent, Inc. is a medical device company that focuses on noninvasive solutions for sleep-disordered breathing, particularly snoring and obstructive sleep apnea (OSA). Founded in 2013, the company emerged from the assets of Ventus Medical. Theravent develops devices that utilize Expiratory Positive Airway Pressure (EPAP) therapy, featuring innovative MicroValve technology to keep airways open during sleep. The flagship product, Theravent Advanced Nightly Snore Therapy, is an FDA-cleared, over-the-counter device designed to effectively treat snoring. It attaches to the nostrils and creates pressure during exhalation to maintain airway openness. Theravent also offers Provent, a prescription device for sleep apnea, which was originally approved by the FDA in 2008. Their products have been clinically proven and have contributed to millions of nights of quiet sleep, with distribution through major retailers like CVS and availability in countries such as Canada, Australia, New Zealand, and South Africa.

• Employees 8
• Founded 2012
• Annual Revenue $10000000